MAP Verified Summary — reported by CBS News
A treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease. CBS News' Natalie Brand reports.
This story was scored across MAP’s five-signal verification framework — Context, Presentation, References, Visibility, and Comparison — as part of Media Alert Press’s independent media credibility index. Read the full original story at CBS News →
Discover more from Media Alert Press
Subscribe to get the latest posts sent to your email.